Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Microdose is a private company focused on the business and ecosystem of psychedelic medicine rather than drug development itself. The company publishes news, analysis, and educational content on scientific breakthroughs, industry developments, investing, and culture in psychedelics, and it also organizes industry events such as Wonderland and Psychedelic Capital. Its offerings appear to center on content, market intelligence, strategy, community building, and business-to-business events for stakeholders across the psychedelic medicine sector. While it operates adjacent to biotech and healthcare, Microdose does not appear to have an internal therapeutic pipeline or proprietary drug programs. The company is best understood as a commercial media and events platform serving the psychedelic healthcare and biotech market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Microdose Psychedelic Insights.